Kiyomi Morita

8PUBLICATIONS
25CO-AUTHORS
Cancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Epigenetics (incl. genome methylation and epigenomics)Haematological tumoursCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Dec 15, 2021
Statistical tests for intra-tumour clonal co-occurrence and exclusivity.

Jack Kuipers, Ariane L Moore, Katharina Jahn

|Jun 17, 2021
Hyper-CVAD plus ofatumumab versus hyper-CVAD plus rituximab as frontline therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: A propensity score analysis.

Koji Sasaki, Hagop M Kantarjian, Kiyomi Morita

|May 11, 2021
Author Correction: Clonal evolution of acute myeloid leukemia revealed by high-throughput single-cell genomics.

Kiyomi Morita, Feng Wang, Katharina Jahn

|May 11, 2021
Leukemia stemness and co-occurring mutations drive resistance to IDH inhibitors in acute myeloid leukemia.

Feng Wang, Kiyomi Morita, Courtney D DiNardo

|Apr 06, 2021
Outcome of patients with chronic myeloid leukemia in lymphoid blastic phase and Philadelphia chromosome-positive acute lymphoblastic leukemia treated with hyper-CVAD and dasatinib.

Kiyomi Morita, Hagop M Kantarjian, Koji Sasaki

|Feb 27, 2021
Outcome of T-cell acute lymphoblastic leukemia/lymphoma: Focus on near-ETP phenotype and differential impact of nelarabine.

Kiyomi Morita, Nitin Jain, Hagop Kantarjian

Pageof 2

Frequent Collaborators

7 joint publications

Guillermo Garcia-Manero

5 joint publications

Courtney D DiNardo

5 joint publications

Marina Konopleva

5 joint publications

Koichi Takahashi